[go: up one dir, main page]

IT1304898B1 - PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS - Google Patents

PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS

Info

Publication number
IT1304898B1
IT1304898B1 IT1998FI000201A ITFI980201A IT1304898B1 IT 1304898 B1 IT1304898 B1 IT 1304898B1 IT 1998FI000201 A IT1998FI000201 A IT 1998FI000201A IT FI980201 A ITFI980201 A IT FI980201A IT 1304898 B1 IT1304898 B1 IT 1304898B1
Authority
IT
Italy
Prior art keywords
receiver
products
pharmaceutical preparations
basic characteristics
antagonist activities
Prior art date
Application number
IT1998FI000201A
Other languages
Italian (it)
Inventor
Alessandro Sisto
Karsten Groeger
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Priority to IT1998FI000201A priority Critical patent/IT1304898B1/en
Publication of ITFI980201A0 publication Critical patent/ITFI980201A0/en
Priority to AU57457/99A priority patent/AU5745799A/en
Priority to PCT/EP1999/006541 priority patent/WO2000014109A1/en
Publication of ITFI980201A1 publication Critical patent/ITFI980201A1/en
Application granted granted Critical
Publication of IT1304898B1 publication Critical patent/IT1304898B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT1998FI000201A 1998-09-08 1998-09-08 PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS IT1304898B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT1998FI000201A IT1304898B1 (en) 1998-09-08 1998-09-08 PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS
AU57457/99A AU5745799A (en) 1998-09-08 1999-09-06 Basic products having antagonistic activity on the nk-1 receptor and their use in pharmaceutical compositions
PCT/EP1999/006541 WO2000014109A1 (en) 1998-09-08 1999-09-06 Basic products having antagonistic activity on the nk-1 receptor and their use in pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998FI000201A IT1304898B1 (en) 1998-09-08 1998-09-08 PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS

Publications (3)

Publication Number Publication Date
ITFI980201A0 ITFI980201A0 (en) 1998-09-08
ITFI980201A1 ITFI980201A1 (en) 2000-03-08
IT1304898B1 true IT1304898B1 (en) 2001-04-05

Family

ID=11352662

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998FI000201A IT1304898B1 (en) 1998-09-08 1998-09-08 PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS

Country Status (3)

Country Link
AU (1) AU5745799A (en)
IT (1) IT1304898B1 (en)
WO (1) WO2000014109A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010958D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
AU2012202459B2 (en) * 2004-03-15 2014-06-12 Janssen Pharmaceutica, N.V. Novel compounds as opioid receptor modulators
CN102786476B (en) 2004-03-15 2017-01-18 詹森药业有限公司 compounds as opioid receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
FR2677361A1 (en) * 1991-06-04 1992-12-11 Adir NOVEL PEPTIDES AND PSEUDOPEPTIDES, TACHYKININ DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GB9113219D0 (en) * 1991-06-19 1991-08-07 Fujisawa Pharmaceutical Co Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
ITFI980201A1 (en) 2000-03-08
ITFI980201A0 (en) 1998-09-08
AU5745799A (en) 2000-03-27
WO2000014109A1 (en) 2000-03-16

Similar Documents

Publication Publication Date Title
DK0941056T3 (en) Sphingomyelinase preparations and their use
IL128800A0 (en) 4-Heteroylpyrazol derivatives and the use thereof as herbicides
HUP0103793A3 (en) N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
NL300395I1 (en) GnRH antagonists modified in positions 5 and 6
AU6503299A (en) High-beta-conglycinin products and their use
IL138212A0 (en) Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
NO305317B1 (en) Sulfonamide endothelin antagonists uses thereof and pharmaceutical preparations
EE04879B1 (en) Synthetic surfactants and their use in the preparation of synthetic surfactants
PT1019358E (en) 3,3-DIARILPROPILLAMINES ITS USE AND PREPARATION
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE69839392D1 (en) IN 1-POSITION SUBSTITUTED 4-CARBAMOYL-1,2,4-TRIAZOL-5-ON DERIVATIVES AND HERBICIDES
HUP0001758A3 (en) Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus, pharmaceutical compositions comprising thereof and their use
AU2841801A (en) Triazolotriazinones and the use thereof
PT1228039E (en) N-GUANIDINOALQUILAMIDES ITS PREPARATION ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
IT1300059B1 (en) PEPTIDES WITH CHEMOTACTIC AND ANTI-HIV ACTIVITIES
PL354921A1 (en) Substituted phenyluracils and their use as herbicides
GB9305120D0 (en) Neuropeptides and their use as insecticides
IT1304898B1 (en) PRODUCTS WITH BASIC CHARACTERISTICS HAVING ANTAGONIST ACTIVITIES ON THE NK-1 RECEIVER AND THEIR USE IN PHARMACEUTICAL PREPARATIONS
NL1007839A1 (en) Formulation and use.
HK1048315A1 (en) Substituted heteroaryloxyacetanilides and their use as herbicides
NZ330551A (en) 2-aryloxy-6-aryl-3,5-difluoropyridines, their use as herbicides and their preparation thereof
AU4318799A (en) Caspase-9 deficient animals and the use thereof
ZA983840B (en) Substituted nitrogen heterocycles their preparations and their use as pesticides
ITMI941135A0 (en) PILIOSTIGMA THONNINGII EXTRACTS, THEIR USE AND FORMULATIONS THAT CONTAIN THEM